Intraperitoneal Chemotherapy (IP): A Paradigm Shift to change Survival in Advanced Epithelial Ovarian Cancer
Journal Title: Gujarat Medical Journal - Year 2017, Vol 72, Issue 1
Abstract
Epithelial ovarian carcinoma (EOC) is usually diagnosed in advanced stage (stage III and IV). EOC is a leading cause of death from gynecologic malignancies in females. The management of the advanced epithelial ovarian cancer is cytoreductive surgery and intravenous chemotherapy. After this treatment also large number of EOC patients recurs in one to three years. There is a need for improvement in the treatment of EOC. Intraperitoneal Chemotherapy (IP) administration is a newer modality of treatment for EOC with improved survival benefits. We report the first case performed in Gujarat of EOCstage III who had neoadjuvant chemotherapy and interval optimal cytoreductive surgery followed by intraperitoneal chemotherapy.
Authors and Affiliations
Akash Shah, Anjana Chauhan
Keywords
Related Articles
- EP ID EP297218
- DOI -
- Views 145
- Downloads 0
Rare Case Report-Bombay Blood Group & its Transfusion Impact
The Bombay Blood Group is the rarest blood group first reported in Bombay, India. 55 year old female patient who is admitted in Zydus Hospital with planned spine surgery . For preoperative major profile blood sample was...
Role of fetal monitoring in high risk pregnancy by fetal electrocardiogram
Background : Non-stress test is an external monitoring of fetal heart rate by electrocardiography. Although intermittent auscultation of fetal heart rate is equivalent to continuous electronic fetal monitoring in detecti...
Cystic spinal schwannomatosis in absence of neurofibromatosis, a rare condition
Schwannoma is a benign tumor arising from a schwann cell involving mainly intradural extramedullary region and schwannomatosis is one of the rare tumor syndrome having multiple schwannomas in absence of features of Neur...
Blood Banker's Challenges & Dilemma In Corporate Setup
NA
Cervical Ectopic Pregnancy
Cervical ectopic pregnancies account for less than 1% of all pregnancies, with an estimated incidence of one in 2500 to one in 18,000 with potential grave consequences if not diagnosed and treated early enough . Its etio...